Cancer-cell-membrane-camouflaged supramolecular self-assembly of antisense oligonucleotide and chemodrug for targeted combination therapy

The cationic amphiphilic chemodrug mitoxantrone replaces the polycation to interact with negatively charged ASO and further self-assembles into ASO/chemodrug nanoparticles for targeted combination gene- and chemotherapy.